PROYECTOS
Project 22239/PDC23
Preclinical Study For Glioblastoma Treatment Based On Therapy With Genetically Modified Pericytes
Funder:
FUNDACION SENECA
edit_calendar
Duration: from 01 January 2024 to 31 December 2024
(12 months)
Current
euro
33,000.00 EUR
Of Regional scope. With a Public character. It has been granted under a regime of Competitive.
Call:
(FUNDACION SENECA)
Subprogram:
PRUEBA DE CONCEPTO: AYUDAS A GRUPOS DE INVESTIGACIÓN PARA LA COMERCIALIZACIÓN Y EXPLOTACIÓN DE RESULTADOS
